BERNARD STRAUS, M.D.; JOSEPH GENNIS, M.D.
During the recent war, extensive investigations were undertaken in the study and cure of malaria. These studies at first were directed particularly toward finding a substitute for quinine, the supply of which had been cut off by the enemy. It was soon found that quinacrine (atabrine), which had been known since 1930 but not sufficiently appreciated because of improper dosage, was a more satisfactory drug than quinine both as a suppressive and as a treatment of the acute malaria attack.1 Quinacrine, however, has no effect on the relapse rate. Its toxic manifestations are not significant. In this country chloroquine, a
Learn more about subscription options.
Register Now for a free account.
STRAUS B, GENNIS J. RADICAL CURE OF RELAPSING VIVAX MALARIA WITH PENTAQUINE-QUININE: A CONTROLLED STUDY(RADICAL CURE OF RELAPSING VIVAX MALARIA WITH PENTAQUINE-QUININE: A CONTROLLED STUDY*). Ann Intern Med. 1950;33:1413–1422. doi: 10.7326/0003-4819-33-6-1413
Download citation file:
Published: Ann Intern Med. 1950;33(6):1413-1422.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only